Overall rank by patents
#24,445
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 20 technology areas, active 2015–2018. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: F02C (GAS-TURBINE PLANTS; AIR INTAKES FOR JET-PROPULSION PLANTS; CONTROLLING FUEL SUPPLY IN AIR-BREATHING JET-PROPULSION PLANTS).
The verdict
Hispano holds 11 US patents across 20 technology areas, rank #24,445 of 50,000 tracked assignees.
Hispano Suiza has been granted 11 US utility patents between 2015 and 2018, placing Hispano Suiza at rank #24,445 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.6 claims per patent with primary concentration in F02C (GAS-TURBINE PLANTS; AIR INTAKES FOR JET-PROPULSION PLANTS; CONTROLLING FUEL SUPPLY IN AIR-BREATHING JET-PROPULSION PLANTS). As a Foreign Corporation, Hispano Suiza is one of the more focused assignees in the PatentsView dataset. By volume, Hispano sits between HH Medical, Llc (11 patents, rank #24,441) and Hoteck Inc. (11 patents, rank #24,449) - the closest US assignees by grant volume. The composite Innovation Score of 30.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 11 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Hispano Suiza's 9.6 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Hispano Suiza against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
HH Medical, LLC
11 patents
HIGHSPOT, INC.
11 patents
HIMOLLA POLSTERMÖBEL GMBH
11 patents
HINOVA PHARMACEUTICALS INC.
11 patents
HITHIUM TECH HK LIMITED
11 patents
HOKUTO CORPORATION
11 patents
HOLLYMATIC CORPORATION
11 patents
HOTECK INC.
11 patents
HISPANO SUIZA
11 patents
What this shows Hispano holds 11 patents at rank #24,445, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Hispano's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
30 Top 67% higher than 33% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 18.2% |
| 2016 | 4 | 36.4% |
| 2017 | 3 | 27.3% |
| 2018 | 2 | 18.2% |
Top 15 of 20 technology areas
Overall rank by patents
#24,445
Across all tracked assignees
30.1 out of 100
How to use this portfolio
Hispano's 11 grants land it in the top 67% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.